Essex Woodlands Management as of Sept. 30, 2020
Portfolio Holdings for Essex Woodlands Management
Essex Woodlands Management holds 8 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Revance Therapeutics (RVNC) | 44.6 | $84M | 3.3M | 25.14 | |
| Venus Concept | 15.3 | $29M | 12M | 2.32 | |
| Tela Bio (TELA) | 13.0 | $24M | 1.5M | 16.54 | |
| Axogen (AXGN) | 12.2 | $23M | 2.0M | 11.63 | |
| Eyepoint Pharmaceuticals | 11.6 | $22M | 42M | 0.52 | |
| Medicinova Com New (MNOV) | 3.1 | $5.8M | 1.1M | 5.24 | |
| Catalyst Biosciences Com New | 0.2 | $338k | 79k | 4.30 | |
| Endologix Com New | 0.0 | $3.0k | 126k | 0.02 |
